Correlation Between Quoin Pharmaceuticals and Erasca

Can any of the company-specific risk be diversified away by investing in both Quoin Pharmaceuticals and Erasca at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quoin Pharmaceuticals and Erasca into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Quoin Pharmaceuticals Ltd and Erasca Inc, you can compare the effects of market volatilities on Quoin Pharmaceuticals and Erasca and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quoin Pharmaceuticals with a short position of Erasca. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quoin Pharmaceuticals and Erasca.

Diversification Opportunities for Quoin Pharmaceuticals and Erasca

0.32

Correlation Coefficient

Quoin Pharmaceuticals  Erasca

Weak diversification

The 3 months correlation between Quoin and Erasca is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Quoin Pharmaceuticals Ltd and Erasca Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Erasca Inc and Quoin Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quoin Pharmaceuticals Ltd are associated (or correlated) with Erasca. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Erasca Inc has no effect on the direction of Quoin Pharmaceuticals i.e., Quoin Pharmaceuticals and Erasca go up and down completely randomly.

Pair Corralation between Quoin Pharmaceuticals and Erasca

Given the investment horizon of 90 days Quoin Pharmaceuticals Ltd is expected to under-perform the Erasca. In addition to that, Quoin Pharmaceuticals is 1.66 times more volatile than Erasca Inc. It trades about -0.06 of its total potential returns per unit of risk. Erasca Inc is currently generating about 0.01 per unit of volatility. If you would invest  383.00  in Erasca Inc on August 31, 2024 and sell it today you would lose (97.00) from holding Erasca Inc or give up 25.33% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	99.79%
Values	Daily Returns

Quoin Pharmaceuticals Ltd  vs.  Erasca Inc

Quoin Pharmaceuticals

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Quoin Pharmaceuticals Ltd are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Quoin Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Erasca Inc

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Erasca Inc are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Erasca may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pair Trading with Quoin Pharmaceuticals and Erasca

The main advantage of trading using opposite Quoin Pharmaceuticals and Erasca positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quoin Pharmaceuticals position performs unexpectedly, Erasca can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Erasca will offset losses from the drop in Erasca's long position.

The idea behind Quoin Pharmaceuticals Ltd and Erasca Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.